COM:TMEPHARMA
TME Pharma N.V.
- Stock
Last Close
0.15
25/11 09:23
Market Cap
6.05M
Beta: -
Volume Today
744.63K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 25K - | 43K 72% | 83K 93.02% | ||||||||
cost of revenue | 3.68M - | 2.64M 28.17% | 1.46M 44.78% | 959K 34.27% | 982K 2.40% | 1.03M 4.79% | 63K 93.88% | 66K 4.76% | 92K 39.39% | ||
gross profit | -3.65M - | -2.60M 28.85% | -1.38M 47.06% | -959K 30.31% | -982K 2.40% | -1.03M 4.79% | -63K 93.88% | -66K 4.76% | -92K 39.39% | ||
selling and marketing expenses | 149K - | 409K 174.50% | 307K 24.94% | 263K 14.33% | |||||||
general and administrative expenses | 1.41M - | 4.97M 253.02% | 2.30M 53.77% | 1.13M 50.65% | 1.29M 14.03% | 1.32M 2.17% | 912K 30.91% | 1.26M 38.71% | 1.93M 52.33% | ||
selling general and administrative expenses | 1.56M - | 5.38M 245.50% | 2.60M 51.58% | 1.40M 46.37% | 1.29M 7.45% | 1.32M 2.17% | 912K 30.91% | 1.26M 38.71% | 1.93M 52.33% | 2.99M 55.11% | |
research and development expenses | 1.50M - | 906K 39.60% | 1.03M 13.47% | 402K 60.89% | 479K 19.15% | 496K 3.55% | 4.02M 709.88% | 10.66M 165.30% | 8.15M 23.54% | 2.65M 67.45% | |
other expenses | |||||||||||
cost and expenses | 13.18M - | 14.32M 8.66% | 8.49M 40.71% | 4.73M 44.31% | 4.32M 8.67% | 3.94M 8.68% | 5.75M 45.82% | 13.45M 133.89% | 12.00M 10.82% | 5.64M 52.98% | |
operating expenses | 9.50M - | 11.68M 22.91% | 7.03M 39.79% | 3.77M 46.39% | 3.34M 11.49% | 2.92M 12.65% | 5.75M 97.29% | 13.45M 133.89% | 12.00M 10.82% | 5.64M 52.98% | |
interest expense | 632K - | 1.29M 104.75% | 2.13M 64.37% | 1.68M 21.11% | 6.76M 302.74% | 3K 99.96% | 5.05M 168,400% | 1.50M 70.25% | 3.40M 126.06% | 1.52M 55.35% | |
ebitda | -12.88M - | -14.10M 9.45% | -8.08M 42.71% | -3.68M 54.43% | -3.96M 7.44% | -810K 79.52% | -5.29M 552.84% | -12.88M 143.61% | -11.63M 9.69% | -12.38M 6.39% | |
operating income | -13.17M - | -14.83M 12.64% | -8.60M 42.02% | -4.73M 44.99% | -4.37M 7.67% | -3.95M 9.59% | -5.77M 46.12% | -13.27M 129.97% | -12.03M 9.33% | -5.64M 53.10% | |
depreciation and amortization | 279K - | 218K 21.86% | 340K 55.96% | 29K 91.47% | 23K 20.69% | 47K 104.35% | 63K 34.04% | 66K 4.76% | 92K 39.39% | ||
total other income expenses net | -629K - | -1.29M 105.72% | -2.13M 64.30% | -659K 69.00% | -6.37M 866.62% | 3.09M 148.48% | -4.64M 250.16% | -1.19M 74.44% | -3.10M 161.35% | 5.64M 282.14% | |
income before tax | -13.79M - | -16.12M 16.88% | -10.72M 33.48% | -5.39M 49.75% | -10.74M 99.24% | -860K 91.99% | -10.41M 1,110% | -14.45M 38.88% | -15.13M 4.66% | ||
income tax expense | 3K - | -22K 833.33% | 27K 222.73% | 1K 96.30% | 1K 0% | 1K 0% | 417K 41,600% | 1K 99.76% | 7K 600% | 6.74M 96,128.57% | |
net income | -13.80M - | -16.10M 16.70% | -10.75M 33.26% | -5.38M 49.89% | -10.73M 99.33% | -861K 91.98% | -10.40M 1,108.48% | -14.45M 38.89% | -15.13M 4.71% | -6.74M 55.49% | |
weighted average shs out | 20.05K - | 20.05K 0% | 16.02K 20.10% | 21.23K 32.54% | 39.79K 87.38% | 123.10K 209.37% | 356.98K 190.00% | 659.85K 84.84% | 1.30M 96.67% | ||
weighted average shs out dil | 20.05K - | 20.05K 0% | 16.02K 20.10% | 21.23K 32.54% | 39.79K 87.38% | 123.10K 209.37% | 356.98K 190.00% | 659.85K 84.84% | 1.30M 96.67% | ||
eps | -688.08 - | -802.97 16.70% | -670.77 16.46% | -253.59 62.19% | -269.77 6.38% | -6.99 97.41% | -29.15 317.02% | -21.90 24.87% | -11.66 46.76% | -0.39 96.66% | |
epsdiluted | -688.08 - | -802.97 16.70% | -670.77 16.46% | -253.59 62.19% | -269.77 6.38% | -6.99 97.41% | -29.15 317.02% | -21.90 24.87% | -11.66 46.76% | -0.39 96.66% |
All numbers in EUR (except ratios and percentages)